Orpyx Medical Technologies Secures $20M Growth Capital to Expand Diabetic Foot Ulcer Prevention Solutions
Slice of Healthcare Team
Sep 30, 2024
Key Highlights
- Orpyx® announces $20 million in growth capital, led by Perceptive Advisors.
- Orpyx Sensory Insole system provides continuous remote monitoring for diabetic foot complications.
- Partnership with Perceptive Advisors aims to prevent diabetic foot ulcers and amputations.
- Funds will accelerate commercial expansion and improve patient outcomes.
Source: Business Wire
Notable Quotes
“ We’re proud to partner with Perceptive Advisors, whose belief in our mission will help us make an even greater impact on the lives of people managing diabetes. ”
Dr. Breanne Everett, CEO at Orpyx
“ Orpyx is an innovator in diabetic foot ulcer prevention...We are excited to partner with the company to support the mission of improving the lives of people at risk from the impacts of peripheral neuropathy and diabetes. ”
Sam Chawla, Portfolio Manager at Perceptive Advisors
-2e14ed90-63f5-4ce1-84fc-3fa9506b84be.png&w=3840&q=75)
